TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2004

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Peter L Greenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.